Cargando…
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
Although multiple sclerosis (MS) is considered to be a CD4, Th17-mediated autoimmune disease, supportive evidence is perhaps circumstantial, often based on animal studies, and is questioned by the perceived failure of CD4-depleting antibodies to control relapsing MS. Therefore, it was interestingly...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474520/ https://www.ncbi.nlm.nih.gov/pubmed/28161400 http://dx.doi.org/10.1016/j.ebiom.2017.01.042 |